Work

KRAS regulation of miRNA: Stepping on the brake to go faster

Year: 2023

Type: article

Source: Molecular Cell

DOI: 10.1016/j.molcel.2023.06.029

Authors: Clint A. Stalnecker, Channing J. Der

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pancreatic Cancer Action Network, Eli Lilly and Company, Sanofi, Deciphera Pharmaceuticals, Mirati Therapeutics, Revolution Medicines, Springworks Therapeutics, National Cancer Institute

Awards: Defining RAS isoform- and mutation-specific roles in oncogenesis, G3823902844, Targeting undruggable RAS for cancer treatment, Integrated Training in Cancer Model Systems, Washington University SPORE in Pancreatic Cancer, G5216334326, Defining the contributions of WT RAS in RAS-mutant lung cancer, Selective Targeting of Pancreatic Cancer SPORE, G93082658

OpenAlex ID: W4384938422

FWCI: 0.254

Cites: 9

Cited by: 2

Related to: 10